Medpace Holdings (MEDP) Cash from Financing Activities (2015 - 2026)

Medpace Holdings (MEDP) has 12 years of Cash from Financing Activities data on file, last reported at -$288.3 million in Q2 2026.

• Quarterly Cash from Financing Activities rose 46.66% year-over-year to -$288.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$249.5 million (up 76.21% YoY) and the FY2025 annual result came in at -$860.4 million, down 458.66% from the prior year.
• Cash from Financing Activities eased to -$288.3 million in Q2 2026, from $12.7 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $22.7 million in Q4 2025 to a low of -$540.6 million in Q2 2025.
• A 5-year average of -$124.9 million and a median of -$67.4 million in 2023 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2024 — Cash from Financing Activities surged 114.54% — and 2025, when it sank 81265.77%.
• Tracing MEDP's Cash from Financing Activities over 5 years: stood at -$131.1 million in 2022, then soared by 101.16% to $1.5 million in 2023, then slumped by 11170.85% to -$168.6 million in 2024, then jumped by 113.48% to $22.7 million in 2025, then slumped by 1368.6% to -$288.3 million in 2026.
• The last three Cash from Financing Activities figures came in at -$288.3 million (Q2 2026), $12.7 million (Q1 2026), and $22.7 million (Q4 2025), per Business Quant data.